Fisher & Paykel Healthcare might be facing a knock of up to 12% of its annual profit if Trump 2.0 presses ahead with harsh tariffs to its neighbours in Mexico and Canada, but investors still back the company’s long history of delivering.

The stock hit a record $39.50 last week and while it’s come off that peak –